Wealthtrust Axiom Trimmed Its Delta Air Lines Del (DAL) Holding; Chemocentryx (CCXI) Shorts Decreased By 17.4%

Delta Air Lines, Inc. (NYSE:DAL) Logo

Wealthtrust Axiom Llc decreased Delta Air Lines Inc Del (DAL) stake by 35.08% reported in 2018Q4 SEC filing. Wealthtrust Axiom Llc sold 7,700 shares as Delta Air Lines Inc Del (DAL)’s stock declined 17.12%. The Wealthtrust Axiom Llc holds 14,250 shares with $711,000 value, down from 21,950 last quarter. Delta Air Lines Inc Del now has $38.09B valuation. The stock increased 0.41% or $0.24 during the last trading session, reaching $58.18. About 291,144 shares traded. Delta Air Lines, Inc. (NYSE:DAL) has declined 8.55% since May 1, 2018 and is downtrending. It has underperformed by 12.92% the S&P500. Some Historical DAL News: 04/04/2018 – DAL: @Delta confirms it’s website chat service was involved in a cyber incident, potentially compromising customer payment information; 12/03/2018 – Late-winter U.S. storm tracking to Northeast prompts flight cancellations; 16/04/2018 – S&PGR Rates Delta Air Lines Inc.’s Prpsd Sr Unsecd Notes ‘BB+’; 07/03/2018 – DELTA SPOKESMAN MICHAEL THOMAS COMMENTS IN EMAIL; 15/05/2018 – DELTA, AIR FRANCE-KLM & VIRGIN STRENGTHEN PARTNERSHIP; 03/04/2018 – Delta Air March Load Factor 86.9; 27/04/2018 – DELTA AIR LINES INC – DECLARED A QUARTERLY DIVIDEND OF $0.305 PER SHARE; 10/04/2018 – Investors Watching Guidance as Delta Air Lines Releases Earnings — Earnings Preview; 27/04/2018 – This is infuriating. Still sitting here @Delta #SorryNotSorry; 12/04/2018 – Delta Sees Strong Travel Demand Offsetting Jump in Fuel Costs

Chemocentryx Inc (NASDAQ:CCXI) had a decrease of 17.4% in short interest. CCXI’s SI was 1.11 million shares in May as released by FINRA. Its down 17.4% from 1.34 million shares previously. With 407,200 avg volume, 3 days are for Chemocentryx Inc (NASDAQ:CCXI)’s short sellers to cover CCXI’s short positions. The SI to Chemocentryx Inc’s float is 4.64%. The stock decreased 1.06% or $0.14 during the last trading session, reaching $13.13. About 3,595 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 1, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/03/2018 ChemoCentryx 4Q EPS 80c; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – ChemoCentryx 4Q Net $39.7M

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It worsened, as 7 investors sold ChemoCentryx, Inc. shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Swiss Bankshares reported 38,400 shares. State Common Retirement Fund invested in 0% or 25,400 shares. Qs Investors Ltd Limited Liability Company reported 643 shares stake. Cadence Capital Ltd Liability Corporation invested in 103,341 shares. Federated Invsts Pa accumulated 0% or 65,761 shares. The Illinois-based One Trading L P has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). The France-based Carmignac Gestion has invested 0.2% in ChemoCentryx, Inc. (NASDAQ:CCXI). Sei Company invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Geode Cap Limited Liability Corp invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Millennium Management Ltd accumulated 16,813 shares or 0% of the stock. Wells Fargo Mn stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Daiwa Securities Gru holds 0% or 269 shares. Spark Investment Mngmt Ltd Limited Liability Company reported 0.09% in ChemoCentryx, Inc. (NASDAQ:CCXI). Bb&T Limited Liability Company holds 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 114,827 shares. State Street Corporation holds 487,355 shares or 0% of its portfolio.

Among 5 analysts covering ChemoCentryx (NASDAQ:CCXI), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ChemoCentryx had 5 analyst reports since November 12, 2018 according to SRatingsIntel. On Wednesday, March 27 the stock rating was upgraded by FBR Capital to “Buy”. The company was maintained on Tuesday, March 12 by H.C. Wainwright. The rating was maintained by Canaccord Genuity on Monday, November 12 with “Buy”. The rating was initiated by Leerink Swann with “Buy” on Thursday, February 14.

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, develops medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company has market cap of $757.94 million. The Company’s lead drug candidate is Avacopan , an orally-administered small molecule that is a selective inhibitor of the complement C5a receptor (C5Ar), which is in Phase III development for the treatment of anti-neutrophil cytoplasmic auto-antibody-associated vasculitis (AAV). It currently has negative earnings. The firm also engages in developing CCX140, an inhibitor of the chemokine receptor known as CCR2 for patients with focal segmental glomerulosclerosis (FSGS), a debilitating kidney disease; Vercirnon for the treatment of patients with moderate-to-severe CrohnÂ’s diseases; CCX872, a selective inhibitor of the human CCR2 that has completed Phase I clinical trial for the treatment of pancreatic cancer; CCX507, which has completed Phase I clinical trial for the treatment of inflammatory bowel diseases; and Th17 cells for the treatment of psoriasis, rheumatoid arthritis, asthma, and multiple sclerosis.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” on April 16, 2019, also Seekingalpha.com with their article: “ChemoCentryx terminates previously announced common stock offering – Seeking Alpha” published on September 28, 2018, Seekingalpha.com published: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” on March 12, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” published on March 28, 2019 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx launches $75M stock offering – Seeking Alpha” with publication date: September 26, 2018.

Since November 7, 2018, it had 0 buys, and 6 sales for $1.47 million activity. $242,370 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) shares were sold by Schall Thomas J.. Shares for $158,790 were sold by Cappel Markus J. on Monday, January 7. 37,893 ChemoCentryx, Inc. (NASDAQ:CCXI) shares with value of $457,747 were sold by KANAYA SUSAN M.

More notable recent Delta Air Lines, Inc. (NYSE:DAL) news were published by: Seekingalpha.com which released: “Fitch Ratings positive on Delta’s financials – Seeking Alpha” on April 29, 2019, also Fool.com with their article: “5 Must-See Highlights From Delta Air Lines’ Q1 Earnings Call – Motley Fool” published on April 16, 2019, Fool.com published: “Why Delta Air Lines Stock Took Off on Tuesday – The Motley Fool” on April 02, 2019. More interesting news about Delta Air Lines, Inc. (NYSE:DAL) were released by: Investorplace.com and their article: “5 Top Stock Trades for Thursday: DAL, LYFT, AMD, NKE, CRM – Investorplace.com” published on April 10, 2019 as well as Investorplace.com‘s news article titled: “Delta Airlines Is Soaring, But Don’t Book a New Seat Here – Investorplace.com” with publication date: April 11, 2019.

Since December 17, 2018, it had 6 buys, and 2 selling transactions for $262.41 million activity. $247,066 worth of Delta Air Lines, Inc. (NYSE:DAL) was bought by Mattson George N. $249,743 worth of Delta Air Lines, Inc. (NYSE:DAL) shares were bought by BLAKE FRANCIS S. $324,598 worth of Delta Air Lines, Inc. (NYSE:DAL) shares were bought by BERKSHIRE HATHAWAY INC. The insider West W Gilbert sold 21,000 shares worth $1.06 million. 60,000 shares were sold by Bastian Edward H, worth $3.00M.

Investors sentiment increased to 0.99 in Q4 2018. Its up 0.23, from 0.76 in 2018Q3. It increased, as 53 investors sold DAL shares while 280 reduced holdings. 92 funds opened positions while 237 raised stakes. 568.97 million shares or 0.15% more from 568.12 million shares in 2018Q3 were reported. Apg Asset Nv accumulated 0.37% or 4.19M shares. Millennium Mgmt Ltd Liability Corporation accumulated 1.65M shares or 0.13% of the stock. Eqis Cap owns 20,870 shares or 0.08% of their US portfolio. Highland Capital Mngmt Limited Liability Corp stated it has 0.5% in Delta Air Lines, Inc. (NYSE:DAL). Teachers Retirement System Of The State Of Kentucky stated it has 640,780 shares or 0.44% of all its holdings. Veritable Limited Partnership holds 0.02% of its portfolio in Delta Air Lines, Inc. (NYSE:DAL) for 20,036 shares. Hsbc Hldgs Public Limited Company has invested 0.05% in Delta Air Lines, Inc. (NYSE:DAL). Two Sigma Ltd Liability Corp reported 13,222 shares. Alphamark Ltd Limited Liability Company owns 301 shares or 0.01% of their US portfolio. Jennison Associates Ltd Liability Corp invested in 522,154 shares or 0.03% of the stock. Service Automobile Association reported 752,700 shares. Markel has invested 0.05% in Delta Air Lines, Inc. (NYSE:DAL). Cibc Mkts owns 66,504 shares or 0.02% of their US portfolio. Regentatlantic Cap Limited Liability Corp holds 0.3% or 70,620 shares. Armstrong Shaw Assocs Incorporated Ct reported 3.65% stake.

Wealthtrust Axiom Llc increased Nutrien Ltd stake by 30,600 shares to 92,641 valued at $4.35 million in 2018Q4. It also upped Iron Mtn Inc New (NYSE:IRM) stake by 28,964 shares and now owns 213,028 shares. Alaska Air Group Inc (NYSE:ALK) was raised too.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *